SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech & Pharma.T.A,
BIB 86.27+6.0%Jan 7 4:00 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Jibacoa who wrote (1710)7/17/2007 4:39:54 PM
From: Jibacoa   of 3722
 
DRRX Also had a good move today after it announced positive results from a 122 patient PIIb of POSIDUR for treatment of post-operative pain in patients undergoing inguinal herniorrhaphy

The stock was up 19.3% at its intraday H of $4.45 at which it traded at 12:45PM & 1:10PM. The UG remained unclosed & the stock was up 18.23% for the day & still trying to retest its intraday H AHs.<g>

bigcharts.marketwatch.com

With the positive results of the PIIb of POSIDUR, DRRX is due to receive $8M "milestone payment" from NTMD, which is a collaborator in the trial.

With some further good news DRRX could start getting off its longer term DT coming from its Sep-Oct double top at the $7.40 level.<g>

bigcharts.marketwatch.com

I am more interested in NTMD, which has been trimming its losses consistently, had better revenues on the 1stQ & had some deals with ELN on Feb12

Bernard
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext